Continuous manufacturing via hot-melt extrusion and scale up: regulatory matters
- 1 February 2017
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 22 (2), 340-351
- https://doi.org/10.1016/j.drudis.2016.11.007
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Inline monitoring and a PAT strategy for pharmaceutical hot melt extrusionInternational Journal of Pharmaceutics, 2013
- Rational Development of Solid Dispersions via Hot-Melt Extrusion Using Screening, Material Characterization, and Numeric Simulation ToolsJournal of Pharmaceutical Sciences, 2013
- Assessment of granulation technologies for an API with poor physical propertiesDrug Development and Industrial Pharmacy, 2012
- Raman spectroscopy for the in-line polymer–drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion processEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Local residence time, residence revolution, and residence volume distributions in twin‐screw extrudersPolymer Engineering & Science, 2007
- Evolution of the peroxide‐induced degradation of polypropylene along a twin‐screw extruder: Experimental data and theoretical predictionsJournal of Applied Polymer Science, 2005
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Development of a Continuous Process for the Industrial Generation of Diazomethane1Organic Process Research & Development, 2002
- A Review on Residence Time Distribution (RTD) in Food Extruders and Study on the Potential of Neural Networks in RTD ModelingJournal of Food Science, 2002
- Practical Use of Continuous Processing in Developing and Scaling Up Laboratory ProcessesOrganic Process Research & Development, 2001